Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alnylam CEO John Maraganore: An Interview With "The Pink Sheet" DAILY (Part 2 of 2)

This article was originally published in The Pink Sheet Daily

Executive Summary

CEO of the RNAi pioneer talks about his company's "5x15" product development strategy and his hopes not to have to access the capital markets anytime soon.

You may also be interested in...



Alnylam CEO John Maraganore: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)

In part two of this interview, the Alnylam chief executive discusses the thought process behind the biotech’s cutback in staff this past January and its $87 million cash raise in February.

Alnylam CEO John Maraganore – An Interview With “The Pink Sheet” DAILY (Part 1 of 2)

The RNAi-pioneering biotech is sitting in a different position than it was a year ago, about to take its lead candidate into pivotal studies and with a new partnership with Arrowhead and $87 million in proceeds from one of the largest follow-on public offerings in recent memory by a biotech firm.

Alnylam CEO John Maraganore - An Interview With "The Pink Sheet" DAILY (Part 1 of 2)

CEO of the RNAI pioneer firm talks about life after the Roche collaboration and how its partnership with Takeda is different.

Related Content

Topics

UsernamePublicRestriction

Register

GB140150

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel